TipRanks
Omada Health, Inc. (OMDA)
NASDAQ:OMDA
US Market
OMDA
Omada Health, Inc.
RESEARCH TOOLSreports
Want to see OMDA full AI Analyst Report?

Omada Health, Inc. (OMDA) Stock Forecast & Price Target

196 Followers
See the Price Targets and Ratings of:

OMDA Analyst Ratings

Strong Buy
10Ratings
Strong Buy
9 Buy
1 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Omada
Health, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

OMDA Stock 12 Month Forecast

Average Price Target

$28.40
▲(21.84% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Omada Health, Inc. in the last 3 months. The average price target is $28.40 with a high forecast of $35.00 and a low forecast of $22.00. The average price target represents a 21.84% change from the last price of $23.31.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","36":"$36","17.25":"$17.25","23.5":"$23.5","29.75":"$29.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$28.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$22.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,17.25,23.5,29.75,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.41,21.532307692307693,22.654615384615383,23.776923076923076,24.89923076923077,26.021538461538462,27.143846153846155,28.266153846153845,29.388461538461538,30.51076923076923,31.63307692307692,32.755384615384614,33.87769230769231,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.41,21.024615384615384,21.639230769230767,22.253846153846155,22.86846153846154,23.483076923076922,24.097692307692306,24.71230769230769,25.326923076923077,25.94153846153846,26.556153846153844,27.17076923076923,27.785384615384615,{"y":28.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.41,20.532307692307693,20.654615384615386,20.776923076923076,20.89923076923077,21.021538461538462,21.143846153846155,21.266153846153845,21.388461538461538,21.51076923076923,21.633076923076924,21.755384615384614,21.877692307692307,{"y":22,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.57,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.73,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.78,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.86,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.9,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.61,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.29,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.38,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.62,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.84,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.41,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$35.00Average Price Target$28.40Lowest Price Target$22.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on OMDA
Craig Hettenbach
Morgan Stanley
Morgan Stanley
$30
Buy
28.70%
Upside
Reiterated
10/13/26
Omada: Buy Rating Reaffirmed as Strong Fundamentals and New Partnerships Support Unchanged $30 Price Target
Wells Fargo Analyst forecast on OMDA
Stan Berenshteyn
Wells Fargo
Wells Fargo
$22
Hold
-5.62%
Downside
Assigned
10/13/26
Analysts Offer Insights on NA Companies: Omada Health, Inc. (NASDAQ: OMDA) and Six Flags Entertainment Corporation (NYSE: FUN)
Freedom Capital Markets Analyst forecast on OMDA
Eugene Mannheimer
Freedom Capital Markets
Freedom Capital Markets
$35
Buy
50.15%
Upside
Reiterated
09/14/26
Analysts Offer Insights on NA Companies: SpaceX (NASDAQ: SPCX) and Omada Health, Inc. (NASDAQ: OMDA)
Barclays Analyst forecast on OMDA
Saket Kalia
Barclays
Barclays
$25→$27
Buy
15.83%
Upside
Reiterated
09/11/26
Barclays Reaffirms Their Buy Rating on Omada Health, Inc. (OMDA)
Canaccord Genuity Analyst forecast on OMDA
Richard Close
Canaccord Genuity
Canaccord Genuity
$28
Buy
20.12%
Upside
Reiterated
09/11/26
Analysts Offer Insights on NA Companies: Reformation, Inc. (NYSE: REF), Omada Health, Inc. (NASDAQ: OMDA) and WEBTOON Entertainment Inc (NASDAQ: WBTN)
Evercore ISI Analyst forecast on OMDA
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$25
Buy
7.25%
Upside
Reiterated
09/11/26
Analysts' Opinions Are Mixed on These NA Stocks: Omada Health, Inc. (NASDAQ: OMDA), Bending Spoons (NASDAQ: BSP) and Graphic Packaging (NYSE: GPK)
BMO Capital Analyst forecast on OMDA
Sean Dodge
BMO Capital
BMO Capital
$24
Buy
2.96%
Upside
Reiterated
09/11/26
Analysts Offer Insights on NA Companies: Omada Health, Inc. (NASDAQ: OMDA) and International Paper Co (NYSE: IP)
BTIG Analyst forecast on OMDA
David Larsen
BTIG
BTIG
$35
Buy
50.15%
Upside
Assigned
09/11/26
Buy Rating Reiterated on Omada Health as Growth, Margin Outlook and Valuation Remain Compelling; Price Target Unchanged at $35
Needham Analyst forecast on OMDA
Ryan MacDonald
Needham
Needham
$28
Buy
20.12%
Upside
Reiterated
09/11/26
Analysts Offer Insights on NA Companies: Omada Health, Inc. (NASDAQ: OMDA) and Reformation, Inc. (NYSE: REF)
J.P. Morgan Analyst forecast on OMDA
Lisa Gill
J.P. Morgan
J.P. Morgan
$26→$30
Buy
28.70%
Upside
Reiterated
08/14/26
Analysts Conflicted on These NA Names: Bending Spoons (NASDAQ: BSP), Alliance Laundry Holdings, Inc. (NYSE: ALH) and Omada Health, Inc. (NASDAQ: OMDA)
Citizens JMP Analyst forecast on OMDA
Constantine Davides
Citizens JMP
Citizens JMP
$21→$27
Buy
15.83%
Upside
Reiterated
07/20/26
Omada Health price target raised to $27 from $21 at CitizensOmada Health price target raised to $27 from $21 at Citizens
Goldman Sachs Analyst forecast on OMDA
David Roman
Goldman Sachs
Goldman Sachs
$26→$25
Buy
7.25%
Upside
Reiterated
06/10/26
David Roman Reaffirms Buy on Omada Health as Strong Q1, Higher 2026 Guidance and Margin Upside Signal Underappreciated Growth
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on OMDA
Craig Hettenbach
Morgan Stanley
Morgan Stanley
$30
Buy
28.70%
Upside
Reiterated
10/13/26
Omada: Buy Rating Reaffirmed as Strong Fundamentals and New Partnerships Support Unchanged $30 Price Target
Wells Fargo Analyst forecast on OMDA
Stan Berenshteyn
Wells Fargo
Wells Fargo
$22
Hold
-5.62%
Downside
Assigned
10/13/26
Analysts Offer Insights on NA Companies: Omada Health, Inc. (NASDAQ: OMDA) and Six Flags Entertainment Corporation (NYSE: FUN)
Freedom Capital Markets Analyst forecast on OMDA
Eugene Mannheimer
Freedom Capital Markets
Freedom Capital Markets
$35
Buy
50.15%
Upside
Reiterated
09/14/26
Analysts Offer Insights on NA Companies: SpaceX (NASDAQ: SPCX) and Omada Health, Inc. (NASDAQ: OMDA)
Barclays Analyst forecast on OMDA
Saket Kalia
Barclays
Barclays
$25→$27
Buy
15.83%
Upside
Reiterated
09/11/26
Barclays Reaffirms Their Buy Rating on Omada Health, Inc. (OMDA)
Canaccord Genuity Analyst forecast on OMDA
Richard Close
Canaccord Genuity
Canaccord Genuity
$28
Buy
20.12%
Upside
Reiterated
09/11/26
Analysts Offer Insights on NA Companies: Reformation, Inc. (NYSE: REF), Omada Health, Inc. (NASDAQ: OMDA) and WEBTOON Entertainment Inc (NASDAQ: WBTN)
Evercore ISI Analyst forecast on OMDA
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$25
Buy
7.25%
Upside
Reiterated
09/11/26
Analysts' Opinions Are Mixed on These NA Stocks: Omada Health, Inc. (NASDAQ: OMDA), Bending Spoons (NASDAQ: BSP) and Graphic Packaging (NYSE: GPK)
BMO Capital Analyst forecast on OMDA
Sean Dodge
BMO Capital
BMO Capital
$24
Buy
2.96%
Upside
Reiterated
09/11/26
Analysts Offer Insights on NA Companies: Omada Health, Inc. (NASDAQ: OMDA) and International Paper Co (NYSE: IP)
BTIG Analyst forecast on OMDA
David Larsen
BTIG
BTIG
$35
Buy
50.15%
Upside
Assigned
09/11/26
Buy Rating Reiterated on Omada Health as Growth, Margin Outlook and Valuation Remain Compelling; Price Target Unchanged at $35
Needham Analyst forecast on OMDA
Ryan MacDonald
Needham
Needham
$28
Buy
20.12%
Upside
Reiterated
09/11/26
Analysts Offer Insights on NA Companies: Omada Health, Inc. (NASDAQ: OMDA) and Reformation, Inc. (NYSE: REF)
J.P. Morgan Analyst forecast on OMDA
Lisa Gill
J.P. Morgan
J.P. Morgan
$26→$30
Buy
28.70%
Upside
Reiterated
08/14/26
Analysts Conflicted on These NA Names: Bending Spoons (NASDAQ: BSP), Alliance Laundry Holdings, Inc. (NYSE: ALH) and Omada Health, Inc. (NASDAQ: OMDA)
Citizens JMP Analyst forecast on OMDA
Constantine Davides
Citizens JMP
Citizens JMP
$21→$27
Buy
15.83%
Upside
Reiterated
07/20/26
Omada Health price target raised to $27 from $21 at CitizensOmada Health price target raised to $27 from $21 at Citizens
Goldman Sachs Analyst forecast on OMDA
David Roman
Goldman Sachs
Goldman Sachs
$26→$25
Buy
7.25%
Upside
Reiterated
06/10/26
David Roman Reaffirms Buy on Omada Health as Strong Q1, Higher 2026 Guidance and Margin Upside Signal Underappreciated Growth
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Omada Health, Inc.

3 Months
Elizabeth Anderson CFAEvercore ISI
Success Rate
6/11 ratings generated profit
55%
Average Return
+12.55%
Copying Elizabeth Anderson CFA's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +12.55% per trade.
1 Year
Craig HettenbachMorgan Stanley
Success Rate
9/14 ratings generated profit
64%
Average Return
+13.11%
Copying Craig Hettenbach's trades and holding each position for 1 Year would result in 64.29% of your transactions generating a profit, with an average return of +13.11% per trade.
2 Years
Craig HettenbachMorgan Stanley
Success Rate
9/14 ratings generated profit
64%
Average Return
+10.51%
Copying Craig Hettenbach's trades and holding each position for 2 Years would result in 64.29% of your transactions generating a profit, with an average return of +10.51% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OMDA Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
8
6
1
3
4
Buy
9
10
17
21
17
Hold
1
1
0
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
17
18
25
23
In the current month, OMDA has received 21 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. OMDA average Analyst price target in the past 3 months is 28.40.
Each month's total comprises the sum of three months' worth of ratings.

OMDA Financial Forecast

OMDA Earnings Forecast

Next quarter’s earnings estimate for OMDA is $0.07 with a range of -$0.03 to $0.12. The previous quarter’s EPS was $0.18. OMDA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year OMDA has Performed in-line its overall industry.
Next quarter’s earnings estimate for OMDA is $0.07 with a range of -$0.03 to $0.12. The previous quarter’s EPS was $0.18. OMDA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year OMDA has Performed in-line its overall industry.

OMDA Sales Forecast

Next quarter’s sales forecast for OMDA is $85.64M with a range of $84.50M to $86.40M. The previous quarter’s sales results were $87.83M. OMDA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year OMDA has Performed in-line its overall industry.
Next quarter’s sales forecast for OMDA is $85.64M with a range of $84.50M to $86.40M. The previous quarter’s sales results were $87.83M. OMDA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year OMDA has Performed in-line its overall industry.

OMDA Stock Forecast FAQ

What is OMDA’s average 12-month price target, according to analysts?
Based on analyst ratings, Omada Health, Inc.’s 12-month average price target is 28.40.
    What is OMDA’s upside potential, based on the analysts’ average price target?
    Omada Health, Inc. has 21.84% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is OMDA a Buy, Sell or Hold?
          Omada Health, Inc. has a consensus rating of Strong Buy which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Omada Health, Inc.’s price target?
            The average price target for Omada Health, Inc. is 28.40. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $35.00 ,the lowest forecast is $22.00. The average price target represents 21.84% Increase from the current price of $23.31.
              What do analysts say about Omada Health, Inc.?
              Omada Health, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of OMDA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.